Maternal Serum GDF15 and Neuropilin-1 as Diagnostic Biomarkers of Third-Trimester Preeclampsia: A Case-Control Study
Journal of Obstetrics, Gynecology and Cancer Research · 01.01.2026 · 12 (1) · 8-15
DOI: 10.24200/jogcr.12.1.8 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Journal of Obstetrics, Gynecology and Cancer Research, online erschienen am 01.01.2026. Verfasst von Qasim Wathiq Abdulsadah und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Abdulsadah, Q. W., Juda, T. M., & Kadhim, H. K. A. (2026). Maternal Serum GDF15 and Neuropilin-1 as Diagnostic Biomarkers of Third-Trimester Preeclampsia: A Case-Control Study. Journal of Obstetrics, Gynecology and Cancer Research, 12(1), 8-15. https://doi.org/10.24200/jogcr.12.1.8
Vancouver
Abdulsadah QW, Juda TM, Kadhim HKA. Maternal Serum GDF15 and Neuropilin-1 as Diagnostic Biomarkers of Third-Trimester Preeclampsia: A Case-Control Study. Journal of Obstetrics, Gynecology and Cancer Research. 2026;12(1):8-15. doi:10.24200/jogcr.12.1.8
BibTeX
@article{Abdulsadah2026,
author = {Abdulsadah, Qasim Wathiq and Juda, Thana Mohammed and Kadhim, Hanan Khudhair Al},
title = {Maternal Serum GDF15 and Neuropilin-1 as Diagnostic Biomarkers of Third-Trimester Preeclampsia: A Case-Control Study},
journal = {Journal of Obstetrics, Gynecology and Cancer Research},
year = {2026},
volume = {12},
number = {1},
pages = {8--15},
doi = {10.24200/jogcr.12.1.8}
}
EUVIMED